Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions

OBJECTIVE: Anti-C1q antibodies (Anti-C1q Ab) are seen in hypocomplementemic urticarial vasculitis syndrome (HUVS), infection-associated vasculitis such as hepatitis C virus-related vasculitis and in autoimmune diseases such as rheumatoid vasculitis, polyarteritis nodosa, giant cell arteritis, vascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayakanthan, Kabeerdoss, Gupta, and Nikhil, Mathew, John, Ravindran, Raheesh, Mahasampth, Gowri, Danda, Debashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Qassim Uninversity 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669508/
https://www.ncbi.nlm.nih.gov/pubmed/29114186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669508/
https://www.ncbi.nlm.nih.gov/pubmed/29114186

Ejemplares similares